Trademark: 90030950
Status Date
Monday, February 13, 2023
Filing Date
Wednesday, July 1, 2020
Published for Opposition
Tuesday, November 17, 2020
Abandoned Date
Monday, February 13, 2023
5 pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Feb 13, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 13, 2023
Abandonment - No Use Statement Filed
Jul 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2022
Sou Extension 3 Granted
Jun 30, 2022
Sou Extension 3 Filed
Jun 30, 2022
Teas Extension Received
Dec 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 22, 2021
Sou Extension 2 Granted
Dec 22, 2021
Sou Extension 2 Filed
Dec 22, 2021
Teas Extension Received
Jul 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 8, 2021
Sou Extension 1 Granted
Jul 8, 2021
Sou Extension 1 Filed
Jul 8, 2021
Teas Extension Received
Jan 12, 2021
Noa E-Mailed - Sou Required From Applicant
Nov 17, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2020
Published For Opposition
Oct 28, 2020
Notification Of Notice Of Publication E-Mailed
Oct 7, 2020
Approved For Pub - Principal Register
Oct 6, 2020
Examiner's Amendment Entered
Oct 6, 2020
Notification Of Examiners Amendment E-Mailed
Oct 6, 2020
Examiners Amendment E-Mailed
Oct 6, 2020
Examiners Amendment -Written
Oct 6, 2020
Assigned To Examiner
Jul 30, 2020
New Application Office Supplied Data Entered
Jul 4, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
